In summary, our work first identified TFCRs in bladder cancer by integrating chromatin accessibility data of ATAC-seq and DNase-seq with TF binding information, and provided a proof of concept for CLIC3 as a regulatory factor of NAT10 protein and of key cellular functions relevant to mRNA ac4C modification. The gene discussed is NAT10; the disease is urinary bladder cancer.